|
Market Closed -
Other stock markets
|
After market 06:00:00 pm | |||
| 167.8 USD | -1.03% |
|
168.5 | +0.42% |
| Apr. 23 | US CDC warns of harmful reactions to fake Botox injections | RE |
| Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
On May 11, 2022, AbbVie Inc announced that at its annual general meeting of shareholders held on May 6, 2022, a shareholder proposal relating to issue a report on board oversight of competition practices, was not approved.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.28% | 300B | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B | |
| -5.21% | 147B |
ABBVIE INC. 
